Gen-Probe Tops Solvay Bid, Offers to Buy Innogenetics for $334M

Jun 04, 2008

NEW YORK (GenomeWeb News) – Gen-Probe has made a bid to buy the Belgian molecular diagnostics company Innogenetics for €215 million ($334 million) in cash, or €6.10 a share, besting an April offer of €5.75 a share from drug maker Solvay.

The offer is roughly 4.3 times Innogenetics’ diagnostic revenues of approximately €51 million in 2007.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Security Policy Change at FDA

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

Fancier than the 'Sit and Reach'

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Collected and Stored

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

This Week in PNAS

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.

Main menu